WS #14665
McDonald's stock plummeted to four-year lows as the CEO warned of persistent inflation and flat traffic, reflecting broader consumer weakness in a high-rate environment. Analyst cuts and weak technicals have accelerated the selloff. Meanwhile, political pressure from GOP midterms is causing the Trump administration to weigh rolling back beef import plans, a move that could temporarily ease food inflation but signals increasing trade protectionism. Shares of major gene-editing companies including CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics declined after Anthropic announced the discovery of ART, a novel CRISPR-like enzyme system found in phage DNA. While the function is currently unknown, the market is pricing in potential IP disruption or competitive threat to existing base-editing platforms. This represents a sector-specific risk event distinct from the broader macro selloff.
Consumer Discretionary and Inflation Pressure
McDonald's stock plummeted to four-year lows as the CEO warned of persistent inflation and flat traffic, reflecting broader consumer weakness in a high-rate environment. Analyst cuts and weak technicals have accelerated the selloff. Meanwhile, political pressure from GOP midterms is causing the Trump administration to weigh rolling back beef import plans, a move that could temporarily ease food inflation but signals increasing trade protectionism.
Shares of major gene-editing companies including CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics declined after Anthropic announced the discovery of ART, a novel CRISPR-like enzyme system found in phage DNA. While the function is currently unknown, the market is pricing in potential IP disruption or competitive threat to existing base-editing platforms. This represents a sector-specific risk event distinct from the broader macro selloff.